B

Biosergen AB
STO:BIOSGN

Watchlist Manager
Biosergen AB
STO:BIOSGN
Watchlist
Price: 40 SEK
Market Cap: 94m SEK

Wall Street
Price Targets

BIOSGN Price Targets Summary
Biosergen AB

Wall Street analysts forecast BIOSGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BIOSGN is 153 SEK with a low forecast of 151.5 SEK and a high forecast of 157.5 SEK.

Lowest
Price Target
151.5 SEK
279% Upside
Average
Price Target
153 SEK
283% Upside
Highest
Price Target
157.5 SEK
294% Upside
Biosergen AB Competitors:
Price Targets
214450
PharmaResearch Co Ltd
81% Upside
4587
PeptiDream Inc
85% Upside
002007
Hualan Biological Engineering Inc
24% Upside
CYTK
Cytokinetics Inc
28% Upside
DAWN
Day One Biopharmaceuticals Inc
136% Upside
CUV
Clinuvel Pharmaceuticals Ltd
108% Upside
SLS
Sellas Life Sciences Group Inc
73% Upside
603087
Gan & Lee Pharmaceuticals
9% Downside

Revenue
Forecast

Revenue Estimate
Biosergen AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Biosergen AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Biosergen AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIOSGN's stock price target?
Price Target
153 SEK

According to Wall Street analysts, the average 1-year price target for BIOSGN is 153 SEK with a low forecast of 151.5 SEK and a high forecast of 157.5 SEK.

Back to Top